CCND1 and prostate cancer: Consistently, when we analyzed the genetic mutation profiles in cBioPortal [23], this showed that all the five genes exhibited gene amplification and increased mRNA levels (except CCND1) in a prostate cancer dataset (Firehose Legacy) from The Cancer Genome Atlas (TCGA) (Figure 1A).